Educational article
Oxazolidinones
Oxazolidinones, including linezolid, act on the bacterial ribosome and formation of the protein-synthesis complex. Their principal clinically relevant activity is against Gram-positive bacteria. Activity against MRSA…
Overview
Oxazolidinones, including linezolid, act on the bacterial ribosome and formation of the protein-synthesis complex. Their principal clinically relevant activity is against Gram-positive bacteria. Activity against MRSA does not establish coverage of every organism in a mixed infection.
Biology and practical meaning
rRNA changes, target methylation and acquired ribosomal-protection genes can reduce activity. cfr, optrA and poxtA mechanisms are relevant to research and surveillance. An unusual phenotype requires confirmation under the local procedure and a quality review.
Spectrum, exposure and AST
Spectrum describes the range of organisms an agent can act against; activity against a particular isolate is assessed separately. Access to the target, target changes, enzymes and efflux can alter activity. Agents in the same class are not completely interchangeable.
Pharmacokinetics describes distribution and elimination; pharmacodynamics links exposure to effect. Blood concentrations and exposure at the infection site can differ. A lower MIC number for a different antibiotic therefore does not establish superior clinical activity.
S, I and R are interpreted using a current standard for the organism–agent pair. Under EUCAST, I means susceptible with increased exposure. It does not mean resistant and does not independently specify a treatment regimen. Decisions also depend on the site, patient, contraindications, interactions and current guidance. This article explains mechanisms and terminology. The 2025 AWaRe classification concerns use policy, while the 2022 AWaRe book has subsequent updates; neither replaces an individual AST result.
Sources
Read next
Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.